Supplemental material
Open access
1,992
Views
1
CrossRef citations to date
0
Altmetric
Report
Anti-citrullinated histone monoclonal antibody CIT-013, a dual action therapeutic for neutrophil extracellular trap-associated autoimmune diseases
Maarten van der Lindena Research and Development, Citryll B.V, Oss, The Netherlands
https://orcid.org/0000-0001-8597-4151View further author information
Sangeeta Kumaria Research and Development, Citryll B.V, Oss, The Netherlands
https://orcid.org/0000-0003-2131-102XView further author information
Daphne Montizaana Research and Development, Citryll B.V, Oss, The Netherlands
https://orcid.org/0000-0001-8514-0317View further author information
Stephanie van Dalena Research and Development, Citryll B.V, Oss, The Netherlands
https://orcid.org/0000-0003-2419-8544View further author information
Annemarie Kipa Research and Development, Citryll B.V, Oss, The Netherlands
https://orcid.org/0009-0003-1686-9755View further author information
Martyn Fosterb Pathology, Experimental Pathology Consultancy, Benfleet, Essex, UKView further author information
, Inge Reinieren-Beerena Research and Development, Citryll B.V, Oss, The NetherlandsView further author information
, Elsa Neubertc Department of Dermatology, Venereology and Allergology, University Medical Center, Göttingen University, Göttingen, Germany;d Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, NetherlandsView further author information
, Luise Erpenbeckc Department of Dermatology, Venereology and Allergology, University Medical Center, Göttingen University, Göttingen, Germany;e Department of General Dermatology and Venereology, Clinic of Skin Diseases, University Medical Center Münster, Münster, Germany
https://orcid.org/0000-0002-6561-472XView further author information
Kelsy Waaijenberga Research and Development, Citryll B.V, Oss, The Netherlands
https://orcid.org/0009-0005-8108-8781View further author information
Tirza Bruurmijna Research and Development, Citryll B.V, Oss, The Netherlands
https://orcid.org/0009-0007-1259-4570View further author information
Rezie te Poelea Research and Development, Citryll B.V, Oss, The NetherlandsView further author information
, Peter van Zandvoorta Research and Development, Citryll B.V, Oss, The NetherlandsView further author information
, Paul Vinka Research and Development, Citryll B.V, Oss, The NetherlandsView further author information
, Eric Meldruma Research and Development, Citryll B.V, Oss, The NetherlandsView further author information
, Helmuth van Esa Research and Development, Citryll B.V, Oss, The NetherlandsView further author information
& Renato G.S. Chirivia Research and Development, Citryll B.V, Oss, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0003-4546-1559View further author information
Article: 2281763
|
Received 13 Jan 2023, Accepted 06 Nov 2023, Published online: 29 Nov 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.